budesonid "nordic prime" 64 mikrogram/dosis næsespray, suspension
nordic prime aps - budesonid - næsespray, suspension - 64 mikrogram/dosis
budesonid "pch" 200 mikrogram inhalationspulver, hård kapsel
pharmachemie b.v. - budesonid - inhalationspulver, hård kapsel - 200 mikrogram
budesonid "pch" 400 mikrogram inhalationspulver, hård kapsel
pharmachemie b.v. - budesonid - inhalationspulver, hård kapsel - 400 mikrogram
budesonid "pharmachemie" 400 mikrogram inhalationspulver, hård kapsel
teva b.v. - budesonid - inhalationspulver, hård kapsel - 400 mikrogram
budesonide "stada" 0,5 mg/ml inhalationsvæske til nebulisator, suspension
stada arzneimittel ag - budesonid - inhalationsvæske til nebulisator, suspension - 0,5 mg/ml
budesonid medical valley 3 mg kapsler med modificeret udløsning, hårde
2care4 aps - budesonid - kapsler med modificeret udløsning, hårde - 3 mg
budesonid sandoz 64 mikrogram/dosis næsespray, suspension
medartuum ab - budesonid - næsespray, suspension - 64 mikrogram/dosis
jorveza
dr. falk pharma gmbh - budesonide - esophageal sygdomme - antidiarrémidler, tarm antiinflammatorisk / antiinfective agenter - jorveza er indiceret til behandling af eosinofiløsofagitis (eoe) hos voksne (over 18 år).
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).